Back to Search Start Over

Epidemiology and evolution of Norovirus in China.

Authors :
Wei N
Ge J
Tan C
Song Y
Wang S
Bao M
Li J
Source :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Nov 02; Vol. 17 (11), pp. 4553-4566. Date of Electronic Publication: 2021 Sep 08.
Publication Year :
2021

Abstract

Norovirus (NoV) has been recognized as a leading cause of gastroenteritis worldwide. This review estimates the prevalence and genotype distribution of NoV in China to provide a sound reference for vaccine development. Studies were searched up to October 2020 from CNKI database and inclusion criteria were study duration of at least one calendar year and population size of >100. The mean overall NoV prevalence in individuals with sporadic diarrhea/gastroenteritis was 16.68% (20796/124649, 95% CI 16.63-16.72), and the detection rate of NoV was the highest among children. Non-GII.4 strains have replaced GII.4 as the predominant caused multiple outbreaks since 2014. Especially the recombinant GII.P16-GII.2 increased sharply, and virologic data show that the polymerase GII.P16 rather than VP1 triggers pandemic. Due to genetic diversity and rapid evolution, predominant genotypes might change unexpectedly, which has become major obstacle for the development of effective NoV vaccines.

Details

Language :
English
ISSN :
2164-554X
Volume :
17
Issue :
11
Database :
MEDLINE
Journal :
Human vaccines & immunotherapeutics
Publication Type :
Academic Journal
Accession number :
34495811
Full Text :
https://doi.org/10.1080/21645515.2021.1961465